Corundum Systems Biology

Corundum Systems Biology develops an approach to accelerate human-centered discovery by converging human-driven data, high-throughput technologies, and advanced computational methodologies. The company focuses on leveraging these integrated systems to advance scientific understanding within biological domains. Their work supports the transition beyond traditional analytical methods towards more holistic insights.

Founded on April 30, 2020, Corundum Systems Biology was established under the leadership of CEO Hidehiko Otake. The company emerged from the insight that significant breakthroughs in human health and well-being require moving past simple statistical associations. This foundational belief drives their mission to build a system of health intelligence capable of simulating and preventing future illnesses.

Corundum Systems Biology serves researchers, entrepreneurs, and groundbreaking companies seeking to make life-changing discoveries. The company operates as an innovation hub dedicated to the betterment of human well-being. Their long-term vision is to shape the future of health by advancing the science of complexity, aspiring to a world where human biology is decoded in real time.